Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Stock Short Interest Declines 46.5%

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) saw a large decline in short interest in September. As of September 15th, there was short interest totaling 24,397 shares, a decline of 46.5% from the August 31st total of 45,624 shares. Based on an average daily trading volume, of 28,177 shares, the short-interest ratio is currently 0.9 days. Currently, 0.2% of the shares of the stock are short sold.

Institutional Investors Weigh In On Columbia Research Enhanced Value ETF

A number of hedge funds have recently made changes to their positions in REVS. Envestnet Asset Management Inc. grew its holdings in shares of Columbia Research Enhanced Value ETF by 13.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 361,667 shares of the company’s stock valued at $11,371,000 after purchasing an additional 44,147 shares during the last quarter. Ruggaard & Associates LLC lifted its stake in Columbia Research Enhanced Value ETF by 0.6% in the 1st quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock valued at $1,500,000 after purchasing an additional 322 shares during the last quarter. World Investment Advisors boosted its position in Columbia Research Enhanced Value ETF by 12.8% in the first quarter. World Investment Advisors now owns 46,609 shares of the company’s stock valued at $1,334,000 after buying an additional 5,283 shares in the last quarter. First Interstate Bank acquired a new stake in Columbia Research Enhanced Value ETF in the first quarter valued at approximately $1,321,000. Finally, Private Advisor Group LLC grew its stake in shares of Columbia Research Enhanced Value ETF by 2.2% during the first quarter. Private Advisor Group LLC now owns 42,408 shares of the company’s stock worth $1,214,000 after buying an additional 922 shares during the last quarter.

Columbia Research Enhanced Value ETF Price Performance

NYSEARCA:REVS traded down $0.17 during trading hours on Wednesday, hitting $32.80. The company’s stock had a trading volume of 366,619 shares, compared to its average volume of 50,876. The stock has a fifty day simple moving average of $33.65 and a 200-day simple moving average of $31.74. The company has a market capitalization of $344.40 million, a P/E ratio of 16.41 and a beta of 0.79. Columbia Research Enhanced Value ETF has a twelve month low of $27.24 and a twelve month high of $34.55.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.